2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole
Structure Info
- Chemspace ID
- CSSB00010082543 (In-Stock Building Blocks)
- CAS
- 1603136-79-3, 1238702-58-3
- MFCD
- MFCD16995677, MFCD16995677
- IUPAC Name
- 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole
- Mol formula
- C15H18BNO3
- Mol weight
- 271 Da
- Catalog Number(s)
- A080080829, A576566, AG029090, AKOS022178002, AR0290Y0, AT51195, ArZ-UP353674, ArZ-UP357958, ArZ-UP370937, BB4LS-EN300-12579513, BBLS00010082543, BBV-79469200, BD211445, BL79260, CS-28783, CSC010082543, EN300-12579513, FCH2776015, ST0291PS, TX0291EO, Y1110370, Y3195166, Z2044754719, ZX-NM260608, ZXC144073, bbls00010082543
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.98
- Heavy atoms count
- 20
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.4
- Polar surface area (Å)
- 44
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSB00010082543
Items Overall 37 items from 6 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 141.41 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 193.20 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 263.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 339.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 422.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 249.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 372.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 530.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 835.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 1,070.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 2,100.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 3,105.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 4,606.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 50 mg | 249.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 100 mg | 372.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 250 mg | 530.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 500 mg | 835.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 1 g | 1,070.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 249.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 372.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 530.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 835.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 1,070.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 2,100.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 5 g | 3,105.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 50 umol | 141.41 | |
| BB4LS EU | 7 days | Germany To: | 95 | 100 umol | 193.20 | |
| BB4LS EU | 7 days | Germany To: | 95 | 200 umol | 263.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 300 umol | 339.00 | |
| BB4LS EU | 7 days | Germany To: | 95 | 500 umol | 422.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 50 mg | 342.10 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 100 mg | 484.00 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 250 mg | 666.60 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 500 mg | 1,019.70 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 1 g | 1,292.50 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 2.5 g | 2,484.90 | |
| 1st Scientific LLC | 7 days | United States To: | 95 | 5 g | 3,648.70 | |
Description: 2-[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole; CAS: 1603136-79-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of {7-chloro-2-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-benzoxazol-5-yl}methanol - CSSB02125605504](/st/structure/200/6b7578c0493286bcc49f2ceccd591515/CC1%253DC%2528C%253DCC%253DC1C1%253DNC2%253DCC%2528CO%2529%253DCC%2528Cl%2529%253DC2O1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 5-formyl-2-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-benzoxazole-7-carbonitrile - CSSB06645087461](/st/structure/200/fe47bf531158c17d3ab07d5278a103e7/Cc1c%2528cccc1-c1nc2cc%2528C%253DO%2529cc%2528C%2523N%2529c2o1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00010080903](/st/structure/200/d7493e2fcfa6f58b083510d34aefbba5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNC%253DCO1.png)
![Chemical structure of 5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2-oxazole - CSSB00010082544](/st/structure/200/da54fec9df87cb6c72c0f7e03a5c0678/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DCC%253DNO1.png)

![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144809](/st/structure/200/493e98023a91f6d044789a829f1f6afd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole - CSSB00000688913](/st/structure/200/0fcc63797e9cdf6eef3aa4b5797ee2a8/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNC%253DCN1.png)
![Chemical structure of 5-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazole - CSSB00160481882](/st/structure/200/b86fc4068ce067f78254b1a971ced413/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DCN%253DCO1.png)
![Chemical structure of 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2-oxazole - CSSB06584797241](/st/structure/200/92b2ba1490d6c90aef6f0fcf14cc6372/CC1%2528C%2529OB%2528C2%253DCC%2528C3%253DNOC%253DC3%2529%253DCC%253DC2%2529OC1%2528C%2529C.png)
